Impact Of Sensory Re-Education Paradigm On Sensation And Quality Of Life In Patients Post-Covid 19 Polyneuropathy (COVID)
Post-COVID-19 Syndrome
About this trial
This is an interventional treatment trial for Post-COVID-19 Syndrome focused on measuring post-covid 19 polyneuropathy, sensory re-education paradigm, sensation, quality of life
Eligibility Criteria
Inclusion Criteria: Patients from both genders (male and female). The age of participants ranged from 30 to 40 years old. Participants were required to live in Egypt during the pre-covid and COVID-19 pandemic. Patients with confirmation of previous covid19 infection PCR TEST. Patients meeting the guide line of world health organization (WHO) of long/post-covid 19 syndromes. Patients with unknown prior neuropathy. Patients with neuropathy confirmed by EDX with a sensory nerve conduction velocity. Exclusion Criteria: Patients with Diabetes mellitus (DM), Rheumatology and Guillain-Barré syndrome (GBS). Infection other than covid19 leading to sensory neuropathy. Traumatic or compressive lesions leading to central nervous system (CNS), peripheral nervous system (PNS) damages. Previous surgeries or medications leading to neuropathy.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
sensory re-education training
traditional treatment
the patients will receive sensory re-education training three times a week for six weeks
the patients will receive traditional treatment three times a week for six weeks